394 results on '"Lenci, Ilaria"'
Search Results
2. Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study
3. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort
4. Trends in liver transplantation for primary sclerosing cholangitis
5. Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication
6. Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
7. Temporal trends of waitlistings for liver transplantation in Italy: The ECALITA (Evolution of IndiCAtion in LIver transplantation in ITAly) registry study
8. Electronic Outpatient Referral System for Liver Transplant Improves Appropriateness and Allows First Visit Triage
9. Safe pregnancy after liver transplantation: Evidence from a multicenter Italian collaborative study
10. FRI-392-YI Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV monoinfection, that parallels HDV replicative and cytolytic activity
11. OS-094 Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBV-DNA in the setting of a limited or even absent HBV reservoir
12. Development of Autoimmune Hepatitis after COVID-19 Infection in Vaccinated Women
13. Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohort
14. Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN)
15. Trends in liver transplantation for primary sclerosing cholangitis.
16. The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation
17. Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study
18. Pitfalls in the reporting of upper endoscopy features in cirrhotic patients
19. Early detection of hepatic encephalopathy after transjugular intrahepatic portsystemic shunt using multiparametric magnetic resonance with spectroscopy
20. Sequence of events leading to primary biliary cholangitis
21. Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis
22. Superiority of the new sex‐adjusted models to remove the female disadvantage restoring equity in liver transplant allocation
23. Response to: Letter to the Editor “Child‐Turcotte‐Pugh score as a model for organ allocation in liver transplantation, perhaps old is still gold”
24. Response to: Importance of gender differences in body composition for liver transplantation and the ‘Sarco‐Model’ study
25. The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients
26. HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay
27. Superiority of the new sex‐adjusted models to remove the female disadvantage restoring equity in liver transplant allocation.
28. Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage
29. Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: risk of HCC recurrence from a large, multicentre retrospective study from Italy
30. Primary sclerosing cholangitis recurrence after liver transplantation: a nationwide survey in Italy
31. The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir
32. Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli
33. Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation
34. Different expression of VEGF and EGFL7 in human hepatocellular carcinoma
35. Donor–Recipient Matching in HCV-Infected Patients
36. Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post‐transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study
37. Successful clinical and virological outcomes of liver transplantation for HDV/HBV‐related disease after long‐term discontinuation of hepatitis B immunoglobulins
38. Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation
39. Secondary bile acids and the biliary epithelia: The good and the bad
40. Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome
41. Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension
42. Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study
43. Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late
44. Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1–4 in Italy
45. Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation
46. Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature
47. Use of Intravascular Ultrasound to Improve Diagnosis and Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction in Patients in the Long-term Follow-up
48. Acquisition of positively charged amino acids in HBsAg C-terminus correlates with HBV-induced liver cancer, hampers HBsAg stability and secretion and promotes cell survival
49. Patients with chronic HCV and decompensated cirrhosis are at risk for MELD purgatory
50. Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.